Skip to Content
SITE MAINTENANCE ON MONDAY, AUGUST 4, 2025

Service may be disrupted between 5:00 & 6:00 AM

Resources

Specialty Drug Management: Strategies to Effectively Control Costs Amid Escalating Prices

Sponsored White Paper

This white paper will examine a range of challenges and actionable strategies for payers to manage specialty drug costs more effectively.

Presented By

Ascella Health

Document Info

Published on Jul 24, 2025

Download and read the full Resource.

Resource Details

Disclaimer

This white paper represents the views of the author, not America’s Health Insurance Plans (AHIP). The publication, distribution or posting of this white paper by AHIP does not constitute a guaranty of any product or service by AHIP.

The rising cost of specialty pharmaceuticals presents a growing concern for payers across the healthcare ecosystem. As more innovative and complex therapies enter the market, particularly in the areas of rare diseases—including autoimmune disorders, chronic conditions, and oncology and hematology-related conditions—the economic burden continues to expand. Specialty drugs now account for over 50% of total prescription drug spending despite serving a comparatively small percentage of the patient population. Without a strategic approach to cost containment, payers face increasing difficulty balancing access, affordability, and budget sustainability.

From optimizing site-of-care decisions to leveraging advanced analytics and implementing value-based contracts, this white paper will examine a range of challenges and actionable strategies for payers to manage specialty drug costs more effectively—with a core focus on integrating effective cost-control methods to improve clinical outcomes and increase member satisfaction.